Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-054334

Pres. & Chief Exec. Officer sold 39,016 shares at an average $31.07 ($1,212,230)

  • Pres. & Chief Exec. Officer acquired 22,902 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Option exercise 10b5-1 +20,356 $2.39 $48,651 41,835 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Sale 10b5-1 −8,421 $30.79 $259,266 33,414 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Sale 10b5-1 −3,374 $30.79 $103,879 28,407 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Sale 10b5-1 −2,866 $30.79 $88,238 24,143 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Sale 10b5-1 −11,935 $31.34 $373,995 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Sale 10b5-1 −4,782 $31.34 $149,849 23,625 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Sale 10b5-1 −4,063 $31.34 $127,318 20,080 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-05 Option exercise 10b5-1 +2,546 $2.39 $6,085 24,025 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-05 Sale 10b5-1 −2,546 $30.68 $78,114 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-05 Sale 10b5-1 −556 $30.68 $17,059 23,069 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-05 Sale 10b5-1 −473 $30.68 $14,512 19,607 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-04 Option exercise · Stock option (right to buy) 10b5-1 −20,356 41,403 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-05 Option exercise · Stock option (right to buy) 10b5-1 −2,546 38,857 D
Open-market sales · 39,016 sh · avg $31.07 · $1,212,230
Loading xslF345X06/wk-form4_1786047267.xml…